Cellens Announces Collaboration With Bruker BioAFM to Advance Mechanobiology Technology for Cancer Detection

Cellens, Inc., an early-stage cancer diagnostic company pioneering in applying mechanobiology and machine learning analysis today announced that it is collaborating with Bruker BioAFM, a business unit of Bruker

BusinesswireJun 25 19:00

Bruker's (NASDAQ:BRKR) 7.1% CAGR Outpaced the Company's Earnings Growth Over the Same Five-year Period

Yahoo FinanceJun 13 20:57

Declining Stock and Solid Fundamentals: Is The Market Wrong About Bruker Corporation (NASDAQ:BRKR)?

Bruker (NASDAQ:BRKR) has had a rough three months with its share price down 30%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive

Simply Wall StJun 11 20:57

S&P 500 Futures Fall In Premarket Trading; Canadian Natural Rscs, Frontline Lag

This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Bruker Corp. (BRKR) was up 3.0% in pre-market tradi

Dow JonesJun 11 19:30

Global Preclinical Imaging Market Insights and Forecast, 2024-2034, Featuring Strategic Analysis of VisualSonics (Fujifilm), Bruker Corporation, Agilent Technologies, Molecubes, MR Solutions, and More

Yahoo FinanceJun 10 21:32

Jefferies Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $85

Jefferies analyst Tycho Peterson maintains $Bruker Corp(BRKR.US)$ with a buy rating, and maintains the target price at $85.According to TipRanks data, the analyst has a success rate of 0.0% and a tota

Futu NewsJun 7 20:31 · Ratings